BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 12679463)

  • 1. Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.
    Kolehmainen M; Uusitupa MI; Alhava E; Laakso M; Vidal H
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1717-22. PubMed ID: 12679463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.
    Niskanen L; Lindi V; Erkkilä A; Sivenius K; Luoma J; Ylä-Herttuala S; Laakso M; Uusitupa MI
    Metabolism; 2003 Feb; 52(2):213-7. PubMed ID: 12601635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
    Vidal-Puig AJ; Considine RV; Jimenez-Liñan M; Werman A; Pories WJ; Caro JF; Flier JS
    J Clin Invest; 1997 May; 99(10):2416-22. PubMed ID: 9153284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships of PPARgamma and PPARgamma2 mRNA levels to obesity, diabetes and hyperinsulinaemia in rhesus monkeys.
    Hotta K; Gustafson TA; Yoshioka S; Ortmeyer HK; Bodkin NL; Hansen BC
    Int J Obes Relat Metab Disord; 1998 Oct; 22(10):1000-10. PubMed ID: 9806316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARγ2 Pro12Ala polymorphism is associated with improved lipoprotein lipase functioning in adipose tissue of insulin resistant obese women.
    López-Alarcón M; Rodríguez-Cruz M; Vital-Reyes VS; Zavala-Ortega MI; Hinojosa-Cruz JC; Canizales-Quinteros S; Fernández J
    Gene; 2012 Dec; 511(2):404-10. PubMed ID: 23036713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.
    González Sánchez JL; Serrano Ríos M; Fernández Perez C; Laakso M; Martínez Larrad MT
    Eur J Endocrinol; 2002 Oct; 147(4):495-501. PubMed ID: 12370112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depot-specific differences in adipose tissue gene expression in lean and obese subjects.
    Lefebvre AM; Laville M; Vega N; Riou JP; van Gaal L; Auwerx J; Vidal H
    Diabetes; 1998 Jan; 47(1):98-103. PubMed ID: 9421381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight loss reduces expression of SREBP1c/ADD1 and PPARgamma2 in adipose tissue of obese women.
    Ribot J; Rantala M; Kesäniemi YA; Palou A; Savolainen MJ
    Pflugers Arch; 2001 Jan; 441(4):498-505. PubMed ID: 11212213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women.
    Valve R; Sivenius K; Miettinen R; Pihlajamäki J; Rissanen A; Deeb SS; Auwerx J; Uusitupa M; Laakso M
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3708-12. PubMed ID: 10523018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
    Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.
    Hara K; Okada T; Tobe K; Yasuda K; Mori Y; Kadowaki H; Hagura R; Akanuma Y; Kimura S; Ito C; Kadowaki T
    Biochem Biophys Res Commun; 2000 Apr; 271(1):212-6. PubMed ID: 10777704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma.
    Chambrier C; Bastard JP; Rieusset J; Chevillotte E; Bonnefont-Rousselot D; Therond P; Hainque B; Riou JP; Laville M; Vidal H
    Obes Res; 2002 Jun; 10(6):518-25. PubMed ID: 12055328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARγ Pro12Ala interacts with fat intake for obesity and weight loss in a behavioural treatment based on the Mediterranean diet.
    Garaulet M; Smith CE; Hernández-González T; Lee YC; Ordovás JM
    Mol Nutr Food Res; 2011 Dec; 55(12):1771-9. PubMed ID: 22102511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population.
    Hamada T; Kotani K; Tsuzaki K; Sano Y; Murata T; Tabata M; Sato S; Sakane N
    Metabolism; 2007 Oct; 56(10):1345-9. PubMed ID: 17884443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals.
    Vaccaro O; Mancini FP; Ruffa G; Sabatino L; Iovine C; Masulli M; Colantuoni V; Riccardi G
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):481-6. PubMed ID: 12354130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.
    Swarbrick MM; Chapman CM; McQuillan BM; Hung J; Thompson PL; Beilby JP
    Eur J Endocrinol; 2001 Mar; 144(3):277-82. PubMed ID: 11248748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.
    Zietz B; Barth N; Spiegel D; Schmitz G; Schölmerich J; Schäffler A
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):60-6. PubMed ID: 11928067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes.
    Rieusset J; Auwerx J; Vidal H
    Biochem Biophys Res Commun; 1999 Nov; 265(1):265-71. PubMed ID: 10548525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation.
    Lindi V; Schwab U; Louheranta A; Laakso M; Vessby B; Hermansen K; Storlien L; Riccardi G; A Rivellese A;
    Mol Genet Metab; 2003 May; 79(1):52-60. PubMed ID: 12765846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?
    Franks PW; Luan J; Browne PO; Harding AH; O'Rahilly S; Chatterjee VK; Wareham NJ
    Metabolism; 2004 Jan; 53(1):11-6. PubMed ID: 14681835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.